Zoetis (ZTS) Assets Average (2013 - 2026)
Zoetis (ZTS) posted quarterly Assets Average of $15.3 billion for Q1 2026, up 8.29% year-over-year from $14.1 billion in Q1 2025, and little changed quarter-over-quarter from $15.3 billion in Q4 2025.
Zoetis (ZTS) Assets Average (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Assets Average for 14 consecutive years, with $15.3 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 8.29% year-over-year to $15.3 billion; the TTM figure through Mar 2026 stood at $15.3 billion (up 8.29% YoY), while the FY2025 annual figure was $14.8 billion, up 4.23% from the prior year.
- Assets Average steadied at $15.3 billion in Q1 2026 per ZTS's latest filing, from $15.3 billion in the prior quarter.
- Across five years, Assets Average topped out at $15.3 billion in Q4 2025 and bottomed at $13.7 billion in Q3 2022.
- Historically, Assets Average has averaged $14.3 billion across 5 years, with a median of $14.3 billion in 2024.
- Annual changes were most pronounced in 2022 — Assets Average slipped 1.19% — and 2026, when it rose 8.29%.
- Zoetis' Assets Average stood at $14.3 billion in 2022, then retreated by 0.72% to $14.2 billion in 2023, then grew by 0.58% to $14.3 billion in 2024, then rose by 7.33% to $15.3 billion in 2025, then decreased by 0.02% to $15.3 billion in 2026.
- Business Quant data shows ZTS's Assets Average at $15.3 billion in Q1 2026, $15.3 billion in Q4 2025, and $14.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 4.33 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.12 Bn |
| Mar 31, 2026 | 15.32 Bn |
| Dec 31, 2025 | 15.32 Bn |
| Sep 30, 2025 | 14.82 Bn |
| Jun 30, 2025 | 14.29 Bn |
| Mar 31, 2025 | 14.15 Bn |
| Dec 31, 2024 | 14.28 Bn |
| Sep 30, 2024 | 14.26 Bn |
| Jun 30, 2024 | 14.26 Bn |
| Mar 31, 2024 | 14.32 Bn |
| Dec 31, 2023 | 14.20 Bn |
| Sep 30, 2023 | 13.93 Bn |
| Jun 30, 2023 | 13.75 Bn |
| Mar 31, 2023 | 14.34 Bn |
| Dec 31, 2022 | 14.30 Bn |
| Sep 30, 2022 | 13.72 Bn |
| Jun 30, 2022 | 13.82 Bn |
| Mar 31, 2022 | 13.88 Bn |
| Dec 31, 2021 | 13.80 Bn |
| Sep 30, 2021 | 13.89 Bn |